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Histone H3 lysine 9 (H3K9) methylation is unevenly distributed in mammalian chromosomes. However, the molecular mechanism
controlling the uneven distribution and its biological significance remain to be elucidated. Here, we show that JMJD1A and JMJD1B
preferentially target H3K9 demethylation of gene-dense regions of chromosomes, thereby establishing an H3K9 hypomethylation
state in euchromatin. JMJD1A/JMJD1B-deficient embryos died soon after implantation accompanying epiblast cell death. Fur-
thermore, combined loss of JMJD1A and JMJD1B caused perturbed expression of metabolic genes and rapid cell death in em-
bryonic stem cells (ESCs). These results indicate that JMJD1A/JMJD1B-meditated H3K9 demethylation has critical roles for early
embryogenesis and ESC maintenance. Finally, genetic rescue experiments clarified that H3K9 overmethylation by G9A was
the cause of the cell death and perturbed gene expression of JMJD1A/JMJD1B-depleted ESCs. We summarized that JMJD1A
and JMJD1B, in combination, ensure early embryogenesis and ESC viability by establishing the correct H3K9 methylated
epigenome.
INTRODUCTION
Posttranslational modifications in the tail region of
core histones are important epigenetic marks linked to
various nuclear functions, including transcriptional
activity control. The discovery of enzymes that add/
remove methyl groups to/from histones suggests that
histone methylation levels are not statically but dynam-
ically controlled (Kooistra and Helin, 2012). So far, indi-
vidual functions of histone methyltransferases or deme-
thylases have been studied extensively, but the role
sharing between methyltransferases and demethylases
for the correct establishment of histone methylated epi-
genome is not yet fully understood.
Histone H3 lysine 9 (H3K9) methylation is considered
as an epigenetic mark of transcriptionally silenced
heterochromatin. The JMJD1 family of proteins, which
includes JMJD1A and its isozyme JMJD1B, reportedly
possesses intrinsic H3K9 demethylating activity (Kim
et al., 2012; Kuroki et al., 2013a; Yamane et al., 2006).
JMJD1A plays important roles in several biological pro-
cesses such as spermiogenesis (Liu et al., 2010; Okada
et al., 2007), metabolism (Inagaki et al., 2009; Tateishi
et al., 2009), and sex determination (Kuroki et al.,
2013b). Recently, JMJD1B was shown to be required for
female fertility (Liu et al., 2015). In contrast to the
individual function of JMJD1A and JMJD1B in post-
natal mice, the role of JMJD1 proteins in early em-
bryogenesis and their functional redundancy are still
unknown.
In this study, we demonstrated that JMJD1A and
JMJD1B are redundantly but essentially required for
mouse development immediately after implantation. We
also demonstrated that JMJD1A and JMJD1B exhibit
pivotal roles inmouse embryonic stem cell (ESC) function
through the correct establishment of H3K9 methylated
epigenome. Not a single depletion but depletion of both
JMJD1A and JMJD1B induced a massive increase in
H3K9 methylation accompanied by rapid cell death
and perturbed gene expression. In control ESCs, dimethy-
lated H3K9 (H3K9me2) was abundant in the gene-poor
regions and scarce in the gene-dense regions of the
chromosomes. Intriguingly, JMJD1A/JMJD1B deficiency
induced a remarkable increase of H3K9me2 in the
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gene-dense regions, causing aberrant H3K9me2 distribu-
tion; high levels of H3K9me2 decorate chromosomes
throughout. This result implies that JMJD1A/JMJD1B
preferentially target H3K9 demethylation at the gene-
dense euchromatin. Finally, we found that the additional
mutation for an H3K9 methyltransferase G9A in a
JMJD1A/JMJD1B-deficient background restored not only
H3K9 overmethylation but also rapid cell death and per-
turbed gene expression phenotypes, indicating collabora-
tive roles of JMJD1A/JMJD1B and G9A not only for the
tuning of the H3K9 methylation levels but also for the
regulation of ESC function. Taking these results together,
we propose that JMJD1A/JMJD1B ensures cellular viability
and transcription accuracy through the establishment of
the correct H3K9 methylated epigenome in early mouse
development.
RESULTS
JMJD1A and JMJD1B Are Essentially Required for Peri-
implantation Development in Mice
Previous studies had demonstrated that JMJD1A and
JMJD1B possess intrinsic H3K9 demethylating activity
(Kim et al., 2012; Kuroki et al., 2013a; Yamane et al.,
2006), suggesting that JMJD1A and JMJD1B may function
in a redundant manner. To evaluate the roles of JMJD1A
and JMJD1B in peri-implantation development, we exam-
ined the expression profiles of JMJD1A and JMJD1B in
developing embryos (Figure 1A). Immunofluorescence
analysis with anti-JMJD1A antibodies revealed that JMJD1A
is expressed in the epiblast and extraembryonic ectoderm at
embryonic day (E) 6.5 (Figure 1A, left). To detect the endog-
enous JMJD1B protein with an anti-FLAG tag antibody, we
Figure 1. JMJD1A and JMJD1B Are Essen-
tial for Mouse Embryogenesis
(A) Immunofluorescence analysis of longi-
tudinal sections of the E6.5 embryos with
JMJD1A (left) and JMJD1B (right). E6.5
wild-type embryos were stained with anti-
JMJD1A antibodies and DAPI (left). E6.5
Jmjd1b+/FlagKI embryos were stained with
anti-FLAG antibodies and DAPI (right).
Fluorescence intensities along the dashed
lines were quantified and plotted on the
right side of the images. Scale bars, 100 mm.
Epi, epiblast; EXC, extraembryonic ecto-
derm; EPC, ectoplacental cone; Dc, decidual
cells. A.U., arbitrary unit.
(B) Jmjd1a+/D; Jmjd1a+/Dmales and females
were crossed, and the resultant embryos
were genotyped at the indicated embryonic
periods. Jmjd1aD/D; Jmjd1aD/D embryos
were found at E6.5, but not at E7.5. #,
growth-retarded embryos.
(C) Gross appearances of Jmjd1a/Jmjd1b
double-deficient embryos at E6.5 (left)
when compared with a littermate control
(right). 1a and 1b represent Jmjd1a and
Jmjd1b, respectively. Scale bar, 100 mm.
(D) Whole-mount immunostaining analysis
for the epiblast marker OCT3/4. Embryos
were counterstained with DAPI and TUNEL
to detect apoptotic cells. Scale bars,
100 mm.
(E) TUNEL-positive cells in the epiblast
lineage were counted and summarized.
Jmjd1a+/D; Jmjd1a+/D, n = 7; Jmjd1aD/D;
Jmjd1aD/D, n = 3 different embryos (bio-
logical replicates). Data are presented as
means ± SD. **p < 0.01 (Student’s t test).
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Figure 2. Depletion of JMJD1A and JMJD1B Induces Growth Arrest in ESCs
(A) List of the established ESC lines and their genotypes. MerCreMer, Cre flanked by mutated estrogen receptor ligand-binding domains.
(B) Time-course analysis of 4OHT-dependent depletion of JMJD1B in Quad-cKO cells.
(C) Immunoblot analyses of JMJD1A/JMJD1B-depleted ESC lines. Whole extracts of the indicated ESC lines were fractionated using
SDS-PAGE and then applied to immunoblot analysis with antibodies against JMJD1A and JMJD1B. JMJD1A and JMJD1B were depleted in
the Quad-cKO cell lines cultured with 800 nM 4OHT for 4 days. Asterisk (*) represents non-specific signals.
(D) The indicated ESC lines were cultured in the presence or absence of 4OHT. Cell numbers were determined every 2 days. Growth arrest
became apparent when the Quad-cKO cell line was cultured in the presence of 4OHT for 4 days (right). In contrast, wild-type (left) and
Tetra-cKO (middle) cells grew in the presence of OHT.
(E) Time-course analysis of JMJD1 depletion-induced cell death. The indicated ESC lines were cultured in the presence of 4OHT, following
which the cells were stained with PI and annexin V and analyzed using flow cytometry.
(F) Expression levels of pluripotency-associated (left) and lineage-associated (right) genes in Quad-cKO cells treated with 4OHT were
examined using RT-qPCR. We used Fgf5, Gata4, and Brachyury as the markers for primitive ectoderm, endoderm, and mesoderm, respec-
tively. Representative data are presented from independent triplicate experiments. Error bars indicate means ± SD derived from technical
replicates.
(legend continued on next page)
1342 Stem Cell Reports j Vol. 10 j 1340–1354 j April 10, 2018
established knockinmouse and ESC lines carryingmodified
Jmjd1b allele (referred as 1b hereafter). In the resultant
lines, 1b+/FlagKI allele produces the JMJD1B protein with a
carboxy-terminal FLAG tag (Figure S1). Immunofluores-
cence analysis of 1b+/FlagKI embryos with anti-FLAG tag
antibody revealed that JMJD1B is expressed in the epiblast,
extraembryonic ectoderm, and ectoplacental cone of E6.5
embryos (Figure 1A, right). We measured and plotted the
signal intensities for JMJD1 proteins in the embryonic line-
ages (Figure 1A, plot analyses). Consequently, JMJD1A and
JMJD1Bwere both found to be abundantly expressed in the
epiblast of the developing embryos, indicating thepotential
roles of JMJD1A and JMJD1B in epiblast development.
We established mutant mice bearing the 1bD allele,
which lacks exons 20–21, corresponding with a portion
of the catalytic JmjC domain (Figure S1). The 1bD/D mice
were born at nearly the expected Mendelian ratio, but
most of them died within a week after birth (Figure S2).
Some of the 1bD/Dmice survived and developed into adults;
however, their body weights were almost half those of the
controls (Figure S2). These phenotypes are in accordance
with those reported in a recent study (Liu et al., 2015). To
evaluate the effects of compound depletion of JMJD1A
and JMJD1B on mouse development, we examined post-
natal animals and embryos derived from the mating of
1a/1b double-heterozygous mutant mice. Among the 109
neonatal offspring, no JMJD1A/JMJD1B-deficient mice
were found, strongly suggesting that JMJD1A/JMJD1B-
deficient mice were embryonically lethal (Figure S2).
Intriguingly, all of the mice carrying three mutant alleles
of 1a or 1b were stillborn, indicating that the gene dosage
of 1a/1b is critical for prenatal development (Figure S2).
Embryos bearing the 1a/1b double-homozygous mutation
were not found in 70 embryos at E7.5, whereas three em-
bryos with this mutation were found in 78 embryos at
E6.5 (Figure 1B). Notably, all JMJD1A/JMJD1B-deficient
embryos were smaller than the controls at this stage (Fig-
ure 1C). These data suggest that JMJD1A/JMJD1B-deficient
embryos display growth retardation and die around E6.5.
To examine the development of JMJD1A/JMJD1B-
deficient embryos in more detail, we performed a whole-
mount immunostaining analysis using antibodies against
OCT3/4, which mark epiblast cells (Figure 1D). Apoptotic
cells were detected by TUNEL labeling (Figure 1D). Strik-
ingly, the mass size of OCT3/4-positive epiblasts in
JMJD1A/JMJD1B-deficient embryos was smaller than those
in the control embryos (Figure 1D, middle panels). We also
found some JMJD1A/JMJD1B-deficient embryos without
detectable epiblast cells (Figure 1D, right panels). TUNEL
counterstaining analysis demonstrated a significant in-
crease in the number of apoptotic cells in the epiblasts of
JMJD1A/JMJD1B-deficient embryos (summarized in Fig-
ure 1E). These data indicate that growth retardation of
JMJD1A/JMJD1B-deficient embryos can be attributed, in
part, to the compromised development of the epiblast cells.
We therefore conclude that JMJD1A and JMJD1B play
redundant but essential roles for post-implantation devel-
opment in mouse.
JMJD1A and JMJD1B Are Essentially Required for ESC
Viability
To further address the roles of JMJD1-mediated H3K9 de-
methylation in early embryogenesis, we used mouse
ESCs, which provide a good tool for studying the develop-
mental process of pre- and post-implantation embryos.
Immunoblot analysis indicated that JMJD1A and JMJD1B
were both expressed in ESCs (Figure 2). We previously
generated ESCs lacking JMJD1A by a simple targeting
method (Inagaki et al., 2009). Also, we have established
ESCs lacking JMJD1B in this study (Figure S1), indicating
that neither JMJD1A nor JMJD1B is essential for ESC sur-
vival. To address the impact of JMJD1A and JMJD1B dou-
ble-deficiencies in ESC function, we tried to establish an
ESC line with conditionally depleted JMJD1 proteins. The
conditional targeting vector of Jmjd1b was constructed
and then introduced into the JMJD1A-deficient ESC line
(Figure S1). To convert functional 1b2lox alleles into defec-
tive 1b1lox alleles in a 4-hydroxy tamoxifen (4OHT)-depen-
dent manner, the MerCreMer (Cre flanked by mutated
estrogen receptor ligand-binding domains) expression
plasmid was also introduced into the homologous recom-
binant lines. We consequently obtained 1a/1b-conditional
knockout (KO) lines named Quad-cKO (Jmjd1aD/D;
Jmjd1b2lox1FRT/2lox2FRT; Mer-Cre-Mer) (Figure 2A). Quad-
cKO cell lines were cultured with 4OHT and then applied
to immunoblot analysis (Figures 2B and 2C). Time-course
(G and H) Rescue of the growth arrest phenotype by exogenous introduction of JMJD1B into Quad-cKO cell line. (G) Expression vectors
for FLAG-tagged wild-type JMJD1B or enzymatically inactive H1561A mutants of JMJD1B were individually and stably introduced into
the Quad-cKO cell line. The expression levels of exogenously expressed proteins were compared by immunoblot analysis.
(H) Comparison of protein expression levels of endogenously expressed JMJD1B and exogenously expressed JMJD1B using anti-
JMJD1B antibody. JMJD1B expression levels were compared between wild-type ESCs and 4OHT-treated Quad-cKO cells expressing
FLAG-JMJD1B-WT.
(I) Quad-cKO cell lines expressing wild-type JMJD1B (left) or the enzymatically inactive H1561Amutant of JMJD1B (right) were cultured in
the presence of 4OHT. Exogenous expression of wild-type JMJD1B rescued the growth arrest phenotype of Quad-cKO cells in the presence of
4OHT, whereas the enzymatically inactive H1561A mutant did not.
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experiments showed that JMJD1B signal disappeared after
the 4OHT treatment for 2 days (Figure 2B). We confirmed
the absence of JMJD1A signals, as well as JMJD1B signals,
in the 4OHT-treated Quad-cKO cells (Figure 2C). We,
thus, successfully generated ESC lines with conditionally
depleted JMJD1 proteins.
Next, we examined the growth potential of Quad-cKO
cell lines. Tetra-cKO (Jmjd1aD/D; Jmjd1b+/2lox2FRT;
Mer-Cre-Mer) cells that carried two disrupted Jmjd1a alleles
and single conditional allele of Jmjd1b were generated as
controls (Figure 2A). The parental wild-type cells (TT2
line) and Tetra-cKO cells could grow exponentially in the
presence of 4OHT (Figure 2D, left and middle panels,
respectively). In contrast, when Quad-cKO cell lines were
cultured in the presence of 4OHT, an increase in cell
numbers was noted during the first 2 days, which was fol-
lowed by a decrease in number (Figure 2D, right panel).
Note that we could not establish cell lines lacking both
JMJD1A and JMJD1B due to severe growth defect in the
Quad-cKO cell lines when the two proteins were depleted.
Taking these results together, we concluded that JMJD1A
and JMJD1B are redundantly but essentially required for
ESC survival.
To examine the cause of growth arrest in ESCs lacking
JMJD1A and JMJD1B, we assessed the cell viability by stain-
ing with propidium iodide (PI) and annexin V (Figure 2E).
The number of early apoptotic cells that stained positively
with annexin V and negatively with PI increased when the
Quad-cKO cell line was cultured in the presence of 4OHT
for 2 days; remarkably, the number further increased with
4OHT treatment for another 2 days (Figure 2E, bottom
panel). In addition, the number of dead cells that stained
positively with both annexin V and PI simultaneously
increased (Figure 2E, bottom panel). The progressive in-
crease in the number of apoptotic cells might account for
the growth defect of ESCs lacking JMJD1A and JMJD1B,
at least in part. In contrast, 4OHT treatment had a moder-
ate effect on the number of apoptotic and dead cells in the
Tetra-cKO cell line (Figure 2E, top panel). We also conduct-
ed cell cycle analysis of Quad-cKO cells by measuring
bromodeoxyuridine (BrdU) incorporation and the DNA
contents (Figure S3). 4OHT treatment did not have a pro-
found effect on cell cycle progression in both Quad-cKO
and Tetra-cKO cell lines. Therefore, the growth defect
phenotype in JMJD1A/JMJD1B-depleted ESCs partly results
from an increase in the apoptotic cell death.
To investigate how JMJD1A/JMJD1B depletion influ-
enced the pluripotency of ESCs, we examined mRNA
expression levels of six pluripotency-associated genes
(Oct3/4, Nanog, Sox2, Klf2, Klf4, and Tcl1) and three
lineage-associated genes (Fgf5, Gata4, and Brachyury) in
4OHT-treated Quad-cKO cells (Figure 2F). The expression
of four pluripotency-associated genes, Oct3/4, Nanog, Klf4,
and Tcl1, was downregulated (Figure 2F, left), whereas
that of the lineage-associated primitive endoderm marker
gene Fgf5was upregulated in 4OHT-treated Quad-cKO cells
(Figure 2F, right). These results indicate that JMJD1A/
JMJD1B depletion in ESCs might compromise the self-
renewal property of pluripotent ESCs and/or prompt their
differentiation.
It is important to elucidate whether the growth arrest of
JMJD1A/JMJD1B-depleted cells was dependent on JMJD1-
mediated enzymatic activity. To address this issue, we
performed rescue experiments using Jmjd1b expression
vectors. Expression vectors for FLAG-tagged wild-type
JMJD1B and catalytically defective JMJD1BH1561A (Fig-
ure S3) were stably introduced into the Quad-cKO cells
(Figure 2G). We confirmed that the protein expression
levels of exogenously introduced JMJD1B were higher
than that of endogenous JMJD1B (Figures 2G and 2H). As
shown in Figure 2I, Quad-cKO cells carrying wild-type
Jmjd1b transgene had a clearly restored growth potential
in the presence of 4OHT. In contrast, the growth potential
of Quad-cKO cells carrying Jmjd1bH1561A transgene was not
restored, even though the expression level of exogenously
introduced JMJD1BH1561A was higher than that of
wild-type (Figure 2G). These findings indicate that the
H3K9 demethylating activity of JMJD1 enzymes is abso-
lutely required for ESC survival.
JMJD1Aand JMJD1B Substantially Contribute toH3K9
Demethylation in ESCs
To address how JMJD1A and JMJD1B contribute to H3K9
methylation status of ESCs, we examined H3K9 methyl-
ation levels of mutant ESCs by immunoblot analysis (Fig-
ures 3A–3C). Dimethylated H3K9 (H3K9me2) was mark-
edly increased in the Quad-cKO cell line when cultured
in the presence of 4OHT for 2 days onward (Figure 3A).
We next compared the H3K9 methylation levels
among wild-type, JMJD1A-deficient, JMJD1B-deficient,
and JMJD1A/JMJD1B-depleted ESCs using a panel of
specific antibodies by immunoblot analysis (Figure 3B) (Ki-
mura et al., 2008). H3K9me1 levels remained unchanged
even after 1a/1b compound mutation (summarized in Fig-
ure 3C, left panel). In contrast, the compoundmutation led
to robust increases in the levels of H3K9me2 and me3
(summarized in Figure 3C, middle and right panels, respec-
tively). Single mutations of 1a or 1b led to only moderate
increases in the levels of H3K9me2 and me3, indicating
that JMJD1A and JMJD1B redundantly catalyze H3K9 de-
methylation in ESCs.
We compared nuclear distribution profiles of H3K9
methylation between wild-type and JMJD1A/JMJD1B-
depleted ESCs by immunocytochemistry. Neither distribu-
tion nor intensity of H3K9me1 signals was affected by
JMJD1A/JMJD1B depletion (Figure 3D). H3K9me2 signals
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were detected mostly at the euchromatic regions in wild-
type nuclei (Figure 3E, left panels). Distribution profiles
of H3K9me2 signals seemed to be unaffected by JMJD1A/
JMJD1B depletion; nevertheless, the signal intensities
were dramatically increased (Figure 3E, right panels).
H3K9me3 were detected mainly at the pericentric hetero-
chromatin as dense signals in both wild-type and
JMJD1A/JMJD1B-depleted cells (Figure 3F). Interestingly,
we observed that JMJD1A/JMJD1B depletion led to a signif-
icant increase in H3K9me3 signals in the euchromatin
(Figure 3F, right panels). These results strongly suggest
that the increase in H3K9me2/3 in JMJD1A/JMJD1B-
depleted ESCs is attributed to the increase in H3K9me2/3
in the euchromatin.
JMJD1A/JMJD1B-Mediated H3K9 Demethylation
Targets Gene-Dense Regions of Chromosomes
The next important question is which loci are targeted by
JMJD1A/JMJD1B-mediated H3K9 demethylation in ESCs.
To address this issue, we performed chromatin immuno-
precipitation (ChIP) analysis using antibodies against
H3K9me2. Mononucleosome was prepared by enzymatic
digestion of ESC chromatin and then applied to ChIP
sequencing (ChIP-seq) analysis (Figure 4). Importantly,
approximately 1.7 times more DNA was immunoprecipi-
tated with anti-H3K9me2 antibody from JMJD1A/
JMJD1B-depleted nuclei than from wild-type nuclei, indi-
cating that JMJD1A/JMJD1B depletion resulted in a
genome-wide increase in H3K9me2 (Figure S4). The distri-
bution profile of H3K9me2 on chromosome 11 is represen-
tatively shown in Figure 4A; the relatively gene-poor region
spans 10–50 M and relatively gene-dense region spans 50–
120 M (Figure 4A, upper panel). H3K9me2 was detected
throughout chromosome 11 in wild-type cells, indicating
high abundance of the H3K9me2marks (Figure 4A, middle
panel). It is intriguing that H3K9me2 distributes evenly
with high levels of methylation in the gene-poor region,
whereas H3K9me2 distributes unevenly with high and
low levels of methylation in the gene-dense region of
chromosome 11 in wild-type cells. In the gene-dense
region, we observed a typical feature between the gene
densities and enrichment of H3K9me2 in wild-type ESCs;
loci with low gene densities were heavily methylated,
while those with high gene densities were hypomethylated
Figure 3. JMJD1A and JMJD1B Substantially Contribute to H3K9 Demethylation in ESCs
(A) Time-course analysis of JMJD1B-depletion-induced increase in H3K9me2 in 4OHT-treated Quad-cKO cells.
(B) Immunoblot analyses of H3K9 methylation levels in the indicated ESC lines.
(C) The methylation levels of H3K9me1 (left), H3K9me2 (middle), and H3K9me3 (right) in the indicated ESC lines were determined by
immunoblot analysis. The intensities of H3K9me signals of wild-type cells were defined as 1. Data are presented as means ± SD
(n = 3 independent experiments). **p < 0.01; ***p < 0.001 (Student’s t test).
(D–F) Nuclear distribution profiles of H3K9me1 (D), H3K9me2 (E), and H3K9me3 (F) in JMJD1A/JMJD1B-depleted ESCs compared with
those in the wild-type ESCs. Scale bars, 5 mm.
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(Figure 4A, middle panel). JMJD1A/JMJD1B depletion re-
sulted in increased levels of H3K9me2 throughout chromo-
some 11 (Figure 4A, bottom panel). These characteristics
were common in the other chromosomes (Figure S4).
Notably, the increase in H3K9me2 levels due to JMJD1A/
JMJD1B depletion in the gene-dense region seemed to be
higher than that in the gene-poor region. To address this
quantitatively, the relationship between the increased
H3K9me2 levels due to JMJD1A/JMJD1B depletion and
gene densities of all chromosomes was statistically evalu-
ated by calculating the average levels of H3K9me2 in com-
parison with the gene densities (number of genes per
500 kb genome). As shown in Figure 4B, there was a posi-
tive correlation between the increased H3K9me2 levels
due to JMJD1A/JMJD1B depletion and gene densities,
implying that JMJD1A/JMJD1B preferentially targets
H3K9 demethylation in these regions (Figure 4B). The dis-
tribution profiles of H3K9me2 with narrower windows in
the gene-poor and gene-dense regions of chromosome 11
are shown in Figures 4C and 4D, respectively. In the
gene-poor region, H3K9me2 levels of JMJD1A/JMJD1B-
depleted cells were approximately one and a half times
higher than that of wild-type cells. In contrast, H3K9me2
levels of JMJD1A/JMJD1B-depleted cells were more than
three times higher than that of wild-type cells, confirming
that JMJD1A/JMJD1B preferentially targets H3K9 demethy-
lation in gene-dense regions (Figures 4C and 4D).
Profound Effect of JMJD1A/JMJD1B Depletion on
Gene Expression
As the enrichment of H3K9 methylation marks is relevant
to transcriptionally silenced heterochromatin, the dis-
torted distribution of H3K9me2 might induce the alter-
ation of gene expression in JMJD1-depleted cells. To
address this, we performed a microarray analysis using
RNAs from wild-type, JMJD1B-deficient, JMJD1A-deficient
(Quad-cKO cell lines), and JMJD1A/JMJD1B-depleted cells
(Quad-cKO cell lines cultured in the presence of 4OHT).
Hierarchical clustering analysis revealed that each of the
genotype-identical sets forms the smallest clusters, indi-
cating that it is not the clonal but the genetic difference
that influences gene expression (Figure 5A). The cluster of
Figure 4. JMJD1A/JMJD1B-Mediated H3K9 Demethylation Targets Gene-Dense Euchromatin
(A) Distribution profiles of H3K9me2 along chromosome 11. The upper panel shows the number (#) of mm10 RefSeq genes smoothed with a
width of 500 kb. The middle and lower panels represent the ratios of normalized read density between ChIP and whole-cell lysate (input)
samples (ChIP/input) in wild-type and JMJD1A/JMJD1B-depleted cells (Quad-cKO+4OHT), respectively. The ratio of ChIP/input >1.6 is
shown in orange.
(B) Correlation between gene density and increased H3K9me2 levels due to JMJD1A/JMJD1B depletion. The x and y axes indicate the
number of mm10 RefSeq genes and the quotient of ChIP/input of Quad-cKO+4OHT divided by ChIP/input of wild-type (WT), respectively,
smoothed with a 500 kb width. The dashed lines represent regression lines.
(C and D) Distribution profile of H3K9me2 in a gene-poor region (C), arrow showing the position in (A), or a gene-dense region (D),
arrowhead showing the position in (A) within chromosome 11. The upper panels show the positions of the protein-coding genes, whereas
lower tracks depict ChIP/input in the indicated samples.
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Figure 5. Depletion of JMJD1A and JMJD1B Alters Gene Expression Profile in ESCs
RNAs were prepared from ESCs and subjected to a microarray analysis using an Affymetrix mouse genome 430 2.0 array.
(A) Hierarchical clustering analysis of gene expression profiles in wild-type cells (TT2 lines), JMJD1A-deficient cells (Quad-cKO cell lines),
JMJD1B-deficient cells, and JMJD1A/JMJD1B-double-depleted cells (Quad-cKO cell lines cultured with 4OHT). The farthest distance was
observed between the cluster of JMJD1A/JMJD1B-double-depleted cells and the other cell clusters, indicating that the compound
depletion of JMJD1A and JMJD1B has the most prominent effect on transcription.
(B) Numbers of genes affected by the JMJD1A and/or JMJD1B depletion in ESCs. Downregulated genes (<0.5-fold) and upregulated genes
(>2.0-fold) due to each mutation are represented as dark and white bars, respectively.
(C) Comparison of mRNA levels in the 204 genes between the indicated samples, which were downregulated by JMJD1A/JMJD1B double
depletion. Heatmap analysis demonstrated that single depletion had a moderate effect on the transcription of these genes compared with
double depletion.
(D) Quantitative analysis of H3K9me2 levels of the genes regulated by JMJD1A and JMJD1B. Averaged increase in H3K9me2 around the
gene bodies down- (blue) and upregulated (red) due to JMJD1A/JMJD1B depletion was plotted. The x axes indicate % gene length; 0% and
100% represent transcription start site and transcription end site, respectively. The y axes indicate the average of the quotient of
ChIP/input of Quad-cKO+4OHT divided by ChIP/input of wild-type.
(legend continued on next page)
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JMJD1A/JMJD1B-depleted cells was the farthest from those
of the other cells, indicating that compound depletion of
JMJD1A and JMJD1B has the most prominent effect on
transcription. Based on this notion, the numbers of genes
up- or downregulated by JMJD1A/JMJD1B double deple-
tion were found to be larger than the numbers affected
by single mutation (Figure 5B, genes are listed in Table S2).
Next, we examined the individual roles of JMJD1A and
JMJD1B on the transcriptional regulation of the 204 genes
that were downregulated by JMJD1A/JMJD1B double
depletion. A heatmap analysis revealed that JMJD1A or
JMJD1B deficiency alone had only moderate effects on
the downregulation of those genes, indicating that JMJD1A
and JMJD1B upregulate these genes in a redundantmanner
(Figure 5C). Among the 204 genes, 134 were downregu-
lated only when both JMJD1A and JMJD1B were depleted
(Figure S5). Gene ontology (GO) analyses demonstrated
that metabolic processes such as one-carbon metabolism
and amino acid biosynthesis were significantly enriched
among the 134 genes (Figure S5). On the other hand, the
genes of many pathways, such as reproductive process, in-
flammatory pathway, and cellular differentiation, were
significantly enriched among the genes upregulated only
when both JMJD1A and JMJD1B were depleted (Figure S5).
To elucidate the cause of distorted gene expression
in JMJD1A/JMJD1B-depleted cells, we examined H3K9
methylation levels in the genomic portion surrounding
the down- and upregulated genes (Figure 5D). We found
that JMJD1A/JMJD1B depletion increased H3K9 methyl-
ation levels of the downregulated genes more profoundly
than those of the upregulated genes (Figure 5D). Therefore,
it is conceivable that these genes are the direct targets of
JMJD1A and JMJD1B.
Because previous studies have demonstrated that H3K9
methylation negatively controls the transcription of genes
includingOct3/4 (Feldman et al., 2006) and aD-type cyclin
Ccnd1 (Shirato et al., 2009), we hypothesized that JMJD1A/
JMJD1B-mediated H3K9 demethylation will upregulate
the transcription of Oct3/4 and Ccnd1. To evaluate this
hypothesis, we examined the H3K9 methylation levels of
Oct3/4 and Ccnd1 promoters and the mRNA expression
levels of Oct3/4 and Ccnd1 in JMJD1A/JMJD1B-depleted
ESCs. As shown in Figures 5E and 5F, JMJD1A/JMJD1B
depletion increased the levels of H3K9me2 at Oct3/4 and
Ccnd1 and decreased their transcription. To further
confirm the effect of JMJD1-mediated H3K9 demethyla-
tion on Oct3/4 and Ccnd1 regulation, we examined the
enrichment of JMJD1A and JMJD1B at Oct3/4 and Ccnd1
loci. ChIP analysis revealed that JMJD1A was significantly
enriched at the promoter regions of Oct3/4 and Ccnd1
in ESCs (Figure 5G). ChIP analysis of 1b+/FlagKI ESCs
demonstrated that endogenous JMJD1B was significantly
enriched at the promoter regions of Oct3/4 and Ccnd1 (Fig-
ure 5H). Taking these results together, we conclude that
JMJD1A and JMJD1B catalyze H3K9 demethylation of
Oct3/4 and Ccnd1 gene promoters, thereby activating their
transcription.
Collaborative Roles of JMJD1A/JMJD1B Demethylases
and G9A Methyltransferase for Tuning the H3K9
Methylation Levels and Regulation of ESC Function
The data presented here suggest that the excess accumula-
tion of H3K9 methylation might cause rapid cell death
and perturbed gene expression in JMJD1A/JMJD1B-
depleted cells. To verify this possibility, we tried to identify
the enzymes responsible for H3K9 overmethylation
in JMJD1A/JMJD1B-depleted cells. We have previously
demonstrated that GLP/G9A methyltransferase complex
catalyzes H3K9 methylation in the euchromatin (Tachi-
bana et al., 2002, 2005). Assuming the strong candidate of
this complex for euchromatic H3K9 overmethylation in
the JMJD1A/JMJD1B-depleted cells, we introduced G9A-
conditional alleles into the Quad-cKO cell line. Conse-
quently, Hexa-cKO cells, in which JMJD1A, JMJD1B, and
G9Acould be inducibly depleted,wereobtained (Figure6A).
Surprisingly, the Hexa-cKO cells demonstrated normal
growth when they were cultured in the presence of 4OHT
(Figure 6B), suggesting that G9A depletion restored the
growth potential of JMJD1A/JMJD1B-depleted ESCs. As ex-
pected by this finding, ESC lines lacking JMJD1A, JMJD1B,
and G9A (named as JGTKO) were easily established from a
pool of Hexa-cKO cells cultured with 4OHT, confirming
that the triple-KO ESCs have normal growth potential
(Figures 6A and 6C). Next, H3K9 methylation levels of the
JGTKO lines were assessed by immunoblot analysis (Figures
6D–6F). The additional G9a mutation induced drastic
reductions in H3K9me2 and H3K9me3 levels in ESCs
with JMJD1A/JMJD1B-deficient background (Figures 6E
and 6F). Taken together, we conclude that G9A is a bona
fide enzyme responsible for the H3K9 overmethylation in
(E) H3K9 methylation levels of the promoter regions of Oct3/4 (left) and Ccnd1 (right) of the indicated ESCs.
(F) mRNA expression levels of Oct3/4 (left) and Ccnd1 (right) of the indicated ESCs.
(G) ChIP analysis for JMJD1A at the promoter regions of Oct3/4 (left) and Ccnd1 (right) with anti-JMJD1A antibodies.
(H) ChIP analysis of JMJD1B at the promoter regions of Oct3/4 (left) and Ccnd1 (right) using anti-FLAG antibody. To detect endogenous
JMJD1B with anti-FLAG antibody, we established knockin ESC line carrying1b+/FlagKI allele, in which the modified 1b allele produces
JMJD1B protein with a FLAG tag at its carboxy terminus (Figure S1).
For (E–H), data are presented as means ± SD from n = 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s t test).
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JMJD1A/JMJD1B-depleted ESCs and that G9A-mediated
H3K9 overmethylation is the cause of cell death in
JMJD1A/JMJD1B-depleted ESCs.
To investigate how G9a mutation altered the genome-
wide distribution of H3K9 methylation, we examined
the H3K9me2 distribution profile of JGTKO cells by
Figure 6. Collaborative Roles of JMJD1A/JMJD1B Demethylases and G9A Methyltransferase for Tuning the H3K9 Methylation
Levels and Regulating ESC Function
(A) Genotypes of the established ESC line. Hexa-cKO cell line carries alleles for the null mutation of Jmjd1a, the conditional mutation of
Jmjd1b, and the conditional mutation of G9a. ESC lines lacking JMJD1A, JMJD1B, and G9A (named JGTKO-1 and JGTKO-7) were established
by cloning from a pool of Hexa-cKO cells cultured in the presence of 4OHT.
(B) Growth curve of Hexa-cKO cell line in the presence or absence of 4OHT.
(C) JMJD1A, JMJD1B, and G9A proteins were absent in JGTKO-1 and JGTKO-7 ESC lines. Whole-cell extracts were fractionated by SDS-PAGE,
and then subjected to immunoblot analysis with the indicated antibodies.
(D–F) G9a mutation rescues the H3K9 overmethylation phenotype of JMJD1A/JMJD1B-double-depleted cells. H3K9me2 and H3K9me3
levels in the indicated cell lines were examined by immunoblot analysis (D) and summarized (E and F, respectively). The intensities
of H3K9me signals of Quad-cKO + 4OHT were defined as 1. Data are presented as means ± SD from n = 3 independent experiments.
***p < 0.001 (Student’s t test).
(G) Distribution profiles of H3K9me2 of JGTKO cells along chromosome 11. The top panel shows the number of mm10 RefSeq genes
smoothed over 500 kb. The middle panels represent the ratios of normalized ChIP/input of ESCs of the indicated genotypes, including
wild-type and JMJD1A/JMJD1B-depleted cells. The ratio of ChIP/input >1.6 is shown in orange.
(H) Correlation between gene density and decreased H3K9me2 levels due to G9a mutation in JMJD1A/JMJD1B-depleted cells. The x and y
axes indicate the number of mm10 RefSeq genes and the quotient of ChIP/input of Quad-cKO+4OHT divided by ChIP/input of JGTKO cells,
respectively, smoothed over 500 kb. Dashed lines represent regression curves.
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Figure 7. G9a Mutation Rescues JMJD1A/JMJD1B-Depletion-Induced Transcriptional Downregulation
(A) Comparison of average expression levels of 204 genes that were downregulated by JMJD1A/JMJD1B depletion between the mutant
ESCs. Introduction of G9a mutation in JMJD1A/JMJD1B-deficient background significantly restored the expression levels of those genes.
***p < 0.001 (Student’s t test).
(B and C) JMJD1A/JMJD1B and G9A antagonistically tune the H3K9 methylation levels of Oct3/4 and Ccnd1 to ensure accurate
transcription. (B) The H3K9me2 levels in the promoter regions of Oct3/4 (left) and Ccnd1 (right) were examined by performing
(legend continued on next page)
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ChIP-seq analysis (Figure 6G). Notably, less than half the
amount of input DNA was immunoprecipitated with
anti-H3K9me2 antibody from JGTKO cell nuclei than
from JMJD1A/JMJD1B-depleted cell nuclei, indicating
that G9A might actually contribute to H3K9 di-methyl-
ation in JMJD1A/JMJD1B-depleted cells (Figure S4).
The distribution profile of H3K9me2 on chromosome 11
of JGTKO cells is shown in Figure 6G. We found that
G9a mutation resulted in decreased H3K9me2 levels
throughout chromosome 11, confirming that G9A sub-
stantially contributes to H3K9 di-methylation in JMJD1A/
JMJD1B-depleted cells. To address the target preference of
G9A-mediated H3K9 methylation, the relationship be-
tween the decreased H3K9me2 levels due to G9amutation
in JMJD1A/JMJD1-depleted cells and gene densities of all
chromosomes was statistically evaluated as in Figure 4B.
No significant differences were detected in G9A-mediated
H3K9 methylation levels between the gene-poor and
gene-dense regions (Figure 6H). These data suggest that
the target preference of G9A-mediated H3K9 methylation
is less strict than that of JMJD1A and JMJD1B-mediated
H3K9 demethylation, which preferentially targets gene-
dense regions (Figure 4B).
G9aMutation Rescues JMJD1A/JMJD1B-Depletion-
Induced Transcriptional Downregulation
To address the question of whether G9a mutation also
restores gene expression profiles in JMJD1A/JMJD1B-
depleted cells, we examined the expression levels of 204
genes in JGTKO cells that were downregulated due to
JMJD1A/JMJD1B depletion. As shown in Figure 7A, G9a
mutation remarkably restored the expression levels of
those genes. To investigate the roles of JMJD1A/JMJD1B-
mediated H3K9 demethylation and G9A-mediated H3K9
methylation in transcription regulation at single-gene
level, we examined H3K9 methylation and mRNA expres-
sion ofOct3/4 andCcnd1 in the serialmutant ESC lines (Fig-
ures 7B and 7C, respectively). ChIP analyses demonstrated
that the elevated H3K9me2 levels were rescued by the
introduction ofG9amutation (Figure 7B), strongly suggest-
ing that H3K9me2 levels of Oct3/4 and Ccnd1 were
regulated by both JMJD1A/JMJD1B-mediated H3K9 deme-
thylation and G9A-mediated H3K9 methylation. mRNA
analyses indicated typical inverse correlations between
the H3K9me2 levels and the expression levels of Oct3/4
and Ccnd1; the decreased mRNA expression levels of
Oct3/4 and Ccnd1 were rescued by G9a mutation (Figures
7B and 7C). Thus, we conclude that the antagonistic activ-
ities between JMJD1A/JMJD1B and G9A collaboratively
contribute to the tuning of H3K9 methylation levels in
Oct3/4 and Ccnd1. We summarize the function of
JMJD1A/JMJD1B in the maintenance of ESCs as follows:
H3K9 demethylases JMJD1A and JMJD1B ensure cell
viability and transcriptional accuracy by removing the
H3K9 methylation marks deposited by G9A in the gene-
dense euchromatin (Figure 7D).
As shown in Figure 6B, JMJD1A/JMJD1B- andG9A-triple-
KO cells clearly re-acquired growth potential, indicating
that ESCs can survive in the absence of JMJD1A/JMJD1B-
and G9A-mediated H3K9 methylation tuning. To address
the possible importance of JMJD1A/JMJD1B- and G9A-
mediated H3K9 methylation tuning for differentiation of
ESCs, we cultured the JMJD1A/JMJD1B/G9A-triple-defi-
cient JGTKO-1 line under differentiating condition
without leukemia inhibitory factor. As shown in Figure S6,
the JGTKO cell line immediately lost growth potential in
the differentiating condition. We further examined the
kinetics of mRNA expression of several pluripotency-
associated genes (Figure S6). In wild-type cells, pluripo-
tency-associated genes were downregulated concomitantly
with differentiation. In contrast, some pluripotency-associ-
ated genes were not downregulated in the JGTKO line in
the differentiating condition (Figure S6). These results indi-
cate that collaborative H3K9 methylation tuning by
JMJD1A/JMJD1B and G9A plays an indispensable role in
the suppression of pluripotency-associated genes when
ESCs undergo differentiation.
DISCUSSION
We previously demonstrated that JMJD1A and JMJD1B
have intrinsic enzymatic activities for H3K9 demethylation
(Kuroki et al., 2013a). Here, we report the functional over-
lap of JMJD1A and JMJD1B in early embryogenesis and ESC
maintenance in mice. As expected, JMJD1A and JMJD1B
ChIP-qPCR analyses. Increased H3K9me2 levels in these genes in JMJD1A/JMJD1B-double-depleted cells were rescued by G9A
depletion. (C) The expression levels of Oct3/4 (left) and Ccnd1 (right) were examined by RT-qPCR analyses. Reduced expression levels
of these genes in JMJD1A/JMJD1B-double-depleted cells were rescued by G9A depletion. mRNA expression levels of wild-type
cells were defined as 1. For (B) and (C), data are presented as means ± SD. n = 3 independent experiments. *p < 0.05; **p < 0.01;
***p < 0.001 (Student’s t test).
(D) Schematic representation of the roles of JMJD1A/JMJD1B in ESCs. JMJD1A/JMJD1B ensure cell viability and transcriptional accuracy
by antagonizing G9a-mediated H3K9 overmethylation in gene-rich euchromatin in ESCs. In wild-type ESCs, JMJD1A/JMJD1B preferentially
remove H3K9 methylation marks from gene-rich euchromatin. The compound loss of JMJD1A/JMJD1B results in G9a-mediated H3K9
overmethylation in euchromatin, thereby inducing cell death and impaired gene expression.
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are both expressed in developing embryos and ESCs
(Figures 1 and 2, respectively). On the other hand, Jmjd1a
single-mutantmice display unique phenotypes, such as de-
fects of spermiogenesis (Liu et al., 2010; Okada et al., 2007),
metabolism (Inagaki et al., 2009; Tateishi et al., 2009), and
sex determination (Kuroki et al., 2013b). We speculate that
Jmjd1a is highly expressed in these tissues and therefore
plays a dominant role in H3K9 demethylation. According
to this notion, protein expression profiles of JMJD1A and
JMJD1B are distinctive in the human tissues (http://www.
humanproteomemap.org/).
We demonstrated that the combined depletion of
JMJD1A and JMJD1B has a synergistic effect on gene
expression (Figure 5). It is plausible that the growth defect
phenotype of JMJD1A/JMJD1B-depleted ESCs is attributed
to distorted gene expression, at least partly. Note that the
GO terms for the multiple metabolic pathways down-
regulated by JMJD1A/JMJD1B deficiency include the one-
carbon and amino acid biosynthetic pathways (Figure S5).
It is feasible that disorders in multiple metabolic pathways
might induce the loss of ESC viability.
Mammalian cells have multiple H3K9 methyltrans-
ferases and demethylases with different product/substrate
specificities and target specificities (Greer and Shi, 2012;
Kooistra and Helin, 2012). The antagonistic activities of
H3K9 methyltransferase and demethylase are considered
to contribute to the tuning of the H3K9methylation levels,
but how and which combination of methyltransferase/
demethylase contributes to this regulation were still unre-
solved. Here, we demonstrated that JMJD1A/JMJD1B de-
methylases and G9A methyltransferase are involved in
the tuning of the H3K9 methylation levels (summarized
in Figure 7D). To the best of our knowledge, this is the first
study revealing the role sharing between demethylase and
methyltransferase for the correct establishment of histone
methylated epigenome. In this context, G9A-mediated
H3K9 methylation seems to exhibit less specificity for the
target region of chromosomes (Figure 6H). According to
this notion, a previous ChIP-seq analysis demonstrated
that G9A is located in almost all chromosomal regions
(Mozzetta et al., 2014). On the other hand, ChIP-seq anal-
ysis in our present study revealed that JMJD1A/JMJD1B-
mediated H3K9 demethylation may preferentially target
gene-dense euchromatin (Figure 4B). How JMJD1A/
JMJD1B exerts target specificity toward euchromatin needs
to be ascertained. Likemost of the histonemodification en-
zymes, JMJD1A and JMJD1B do not contain typical DNA
recognition motifs, strongly suggesting that the target
specificity of these proteins is dependent on the interaction
of other proteins. JMJD1A and JMJD1B bear the signa-
ture LXXLL motif indicative of a protein-protein interac-
tion with the nuclear receptors. It was reported that
JMJD1A is recruited to androgen-receptor target genes in
a hormone-dependent manner (Yamane et al., 2006). A
recent study revealed that phosphorylation of JMJD1A
strengthens the binding capacity to binding partner pro-
teins, such as PPARg (Abe et al., 2015). However, as shown
in Figure 4D, it seems likely that JMJD1A/JMJD1B-medi-
ated H3K9 demethylation can target megabase ranges of
the chromosomal region. Thus, it is also conceivable that
JMJD1A/JMJD1B forms a complex with a nuclear protein,
which can recognize the global chromatin structure rather
than specific DNA sequences.
Unexpectedly, our results indicate that JMJD1A/
JMJD1B- and G9A-mediated H3K9 methylation tuning is
dispensable for the maintenance of ESCs (Figure 6B). On
the other hand, this tuning machinery seems to play an
indispensable role when ESCs undergo differentiation
because the downregulation of pluripotency-associated
genes was compromised in the JGTKO line when cultured
in the differentiating condition (Figure S6). A previous
study demonstrated that the forced expression of protein
kinase A in ESCs induces cellular differentiation concom-
itantly withG9A-mediated H3K9methylation of theOct3/
4 locus (Yamamizu et al., 2012).We demonstrated that the
Oct3/4 locus undergoes not only G9A-mediated H3K9
methylation but also JMJD1A/JMJD1B-mediated H3K9
demethylation to ensure correct expression levels (Figures
7B and 7C). It is plausible that the collaboration of
JMJD1A/JMJD1B-mediated H3K9 demethylation and
G9A-mediated H3K9 methylation may be essentially
required for the rearrangement of H3K9methylated epige-
nome upon differentiation. Based on the result that G9a
mutation rescued compromised gene expression due to
JMJD1A/JMJD1B depletion (Figure 7A), we speculate that
the fine-tuning of H3K9 methylation by JMJD1 and G9A
may contribute to transcriptional regulation of not only
Oct3/4 but also other genes important for ESC function.
It has been demonstrated that lysine methyltransferases
and demethylases regulate methylation dynamics not only
for histones but also for non-histone proteins (Hamamoto
et al., 2015). Most recently, it was demonstrated that the
GLP/G9A complex methylates lysine residues within the
TARK motif of DNA Ligase 1, which is similar to the H3K9
methylation within the TARK motif of histone H3 (Ferry
et al., 2017). To the best of our knowledge, the contribution
of JMJD1A and JMJD1B toward the demethylation of non-
histone protein substrates has not been reported. The possi-
bility that JMJD1A/JMJD1B and G9A regulate methylation
of non-histone proteins warrants further investigation.
Note that the levels of H3K9me2 and H3K9me3 in the
triple-KO cells were slightly but significantly higher than
those in the G9a-deficient cells (Figures 6D–6F). These
data indicate that JMJD1A and JMJD1B demethylate the
H3K9me2 and H3K9me3 marks deposited by H3K9 meth-
yltransferase(s) other than G9A. We propose that the
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balance in H3K9 methylation levels is maintained in a
highly orchestrated manner, governed by multiple en-
zymes for methylation and demethylation.
EXPERIMENTAL PROCEDURES
Generation of Mutant Mice and ESCs
Serial knockin targeting vectors were constructed by the bacterial
artificial chromosome recombineering technique (Copeland
et al., 2001) and then introduced into the ESC line TT2. Detailed
information for the generation of mutant mice and ESCs is
described in Supplemental Information. All animal experiments
were performed under the animal ethical guidelines of Tokushima
University (experiment number 14,108, approved by The Ethics
Committee of Tokushima University for Animal Research) and
Kyoto University (experiment number A12-6-2, approved by Ani-
mal Experimentation Committee of Kyoto University).
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